Gabapentin
Product Images NDC 50090-5045

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50090-5045). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Image 01)

Figure 1 (Image 01)
This is a chart showing the mean pain score for individuals who participated in a study of two types of Parkinson's disease medication - one with a fixed dose, and one with titration. The chart also includes the results for a placebo group and a group taking Gabapentin at a dosage of 3600 mg/day. The data is shown for baseline and various time points up to four weeks.*
FDA Label Image

Figure 2 (Image 02)

Figure 2 (Image 02)
This is a chart showing the results of a 4-week fixed dose period study on the effect of Gabapentin on pain. The graph shows the mean pain score over the course of the study. The study involved a placebo group and two Gabapentin groups, one taking 1800 mg/day and the other taking 2400 mg/day.*
FDA Label Image

Figure 3 (Image 03)

Figure 3 (Image 03)
FDA Label Image

Cockcroft And Gault Equation (Image 04)

Cockcroft And Gault Equation (Image 04)
FDA Label Image

Gabapentin Structural Formula (Image 05)

Gabapentin Structural Formula (Image 05)
FDA Label Image

Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Image 09)

Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Image 09)
FDA Label Image

Label Image (Lbl500905045)

Label Image (Lbl500905045)
This is a medication called Gabapentin available in tablet form in a bottle of 90 tablets. The dosage strength is 800 mg. The prescription label indicates that it should be stored at a temperature between 8 to 10 degrees Celsius and dispensed in 7 doses. The first two lines of the text are not coherent.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.